Ideaya Biosciences Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | 39.9 | 20.9 | 27.9 | 19.4 | 27.1 | 32.5 | 13.5 | 18.3 | 12.3 | 17.2 | 14.0 | 29.3 | 69.0 | 99.3 | 212.7 | 228.8 | 696.5 | 320.7 | 207.0 | 265.4 | 11.4 | 14.0 | 13.1 | 14.7 | |
| – | – | – | – | – | 1.6 | 1.6 | 1.5 | 0.9 | 1.7 | 1.8 | 2.1 | 3.2 | 2.9 | 3.0 | 3.0 | 1.5 | 2.0 | 1.7 | 2.5 | 2.0 | 2.6 | 3.2 | 3.7 | 3.5 | 2.9 | 2.3 | 2.1 | 1.4 | 1.9 | 2.2 | 3.0 | 3.2 | 2.9 | |
| – | – | – | – | – | – | – | – | – | – | 31.0 | 17.3 | 22.8 | 16.9 | 24.1 | 29.3 | 11.8 | 16.7 | 10.3 | 15.9 | 12.6 | 27.0 | 62.6 | 92.7 | 205.7 | 213.5 | – | 308.7 | 188.5 | 249.1 | 10.0 | 13.5 | 12.4 | 13.5 | |
| – | – | – | – | – | – | – | – | – | – | 6.2 | 7.4 | 15.0 | 13.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -19.5% | -21.8% | -26.8% | -47.9% | -14.3% | 16.2% | 13.5% | 6.7% | 7.2% | -5.5% | -6.4% | -14.7% | -13.5% | -13.8% | -10.3% | -14.9% | -8.4% | -7.2% | -5.1% | -4.1% | -4.9% | -5.6% | -11.2% | -18.5% | -16.0% | -4.3% | -2.4% | -3.0% | -5.5% | |
| Margins | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | 84.9% | 92.9% | 52.9% | 23.5% | -19.3% | -52.0% | 2.1% | 39.6% | 93.9% | 93.8% | 92.3% | 92.4% | 85.1% | 83.0% | 73.6% | 65.0% | -7.4% | 45.2% | -952.0% | -1,996.7% | -6.5% | -43.9% | -50.7% | -13.3% | |
| – | – | – | – | – | – | – | – | – | – | -461.5% | -180.9% | -119.5% | -85.7% | -104.6% | -179.9% | -172.7% | -229.2% | -109.1% | -122.7% | -157.1% | -187.8% | -506.5% | -574.9% | -1,026.6% | -1,600.1% | -5,729.1% | -4,671.1% | -5,147.8% | -5,488.9% | -97.2% | -72.8% | -81.4% | -92.7% | |
| – | – | – | – | – | – | – | – | – | – | -447.7% | -176.6% | -117.5% | -84.5% | -103.2% | -178.1% | -170.8% | -226.0% | -105.6% | -115.2% | -143.9% | -164.3% | -439.5% | -483.0% | -831.3% | -1,285.3% | -4,540.4% | -3,921.1% | -4,386.9% | -4,740.0% | -74.8% | -52.0% | -62.2% | -74.8% | |
| – | – | – | – | – | – | – | – | – | – | 645.2% | 281.5% | 185.9% | 140.6% | -148.9% | -209.1% | -198.9% | -247.6% | -169.5% | -177.9% | -207.5% | -245.6% | -495.6% | -502.9% | -869.7% | -1,123.3% | -3,907.0% | -3,592.0% | -3,828.2% | -4,246.5% | -49.1% | -33.6% | -39.0% | -81.2% | |
| Returns | ||||||||||||||||||||||||||||||||||
| – | – | – | – | -47.5% | -34.7% | -36.0% | -41.8% | -49.9% | -26.8% | -20.5% | -17.4% | -13.5% | -12.5% | -11.5% | -16.5% | -19.0% | -24.5% | -14.3% | -16.8% | -20.5% | -14.8% | -20.3% | -18.2% | -13.8% | -16.5% | -15.1% | -25.9% | -30.0% | -34.6% | -14.7% | -11.1% | -14.9% | -14.6% | |
| – | – | – | -35.6% | -41.2% | -31.4% | -32.5% | -37.1% | -43.7% | -25.0% | -13.3% | -11.6% | -9.7% | -9.1% | -9.2% | -13.0% | -15.3% | -19.5% | -12.8% | -15.1% | -18.7% | -14.1% | -19.4% | -17.4% | -13.4% | -15.8% | -14.4% | -24.4% | -27.9% | -31.9% | -13.6% | -10.2% | -13.6% | -13.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||
| 13 | – | – | – | -28 | -87 | -38 | -33 | -34 | -146 | -80 | -70 | -135 | -89 | -107 | -90 | -54 | -47 | -100 | -67 | -65 | -101 | -150 | -155 | -107 | -182 | – | -84 | -130 | -114 | -299 | -112 | -157 | -271 | |
| – | – | – | -50.7% | 86.7% | 90.4% | 90.3% | 88.8% | 87.5% | 93.3% | 64.8% | 66.5% | 71.5% | 73.2% | 79.5% | 79.1% | 80.4% | 79.7% | 89.7% | 90.1% | 91.5% | 95.1% | 95.3% | 95.7% | 97.3% | 95.7% | 95.2% | 94.2% | 93.0% | 92.2% | 92.1% | 92.2% | 91.0% | 91.5% | |
| 0.0 | – | – | – | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||
| – | – | – | -2.41 | -1.96 | -2.11 | -1.97 | -2.08 | -2.19 | -2.20 | -1.41 | -1.18 | -0.99 | -0.91 | -0.97 | -1.29 | -1.42 | -1.70 | -1.28 | -1.22 | -1.41 | -1.32 | -1.72 | -1.73 | -1.72 | -1.97 | -2.07 | -3.14 | -3.48 | -3.75 | -1.79 | -1.28 | -1.58 | -1.90 | |
| – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.32 | 0.67 | 0.84 | 1.08 | 0.94 | 0.73 | 0.83 | 0.75 | 1.21 | 1.06 | 0.98 | 0.80 | 0.39 | 0.36 | 0.21 | 0.15 | 0.05 | 0.08 | 0.08 | 0.08 | 2.40 | 2.47 | 2.54 | 2.54 | |
| 0.73 | – | – | -3.44 | 4.12 | 6.09 | 5.48 | 4.97 | 4.40 | 8.19 | 6.88 | 6.80 | 7.34 | 7.31 | 8.41 | 7.83 | 7.48 | 6.97 | 8.97 | 7.26 | 6.90 | 8.92 | 8.47 | 9.52 | 12.45 | 11.95 | 13.70 | 12.13 | 11.59 | 10.85 | 12.18 | 11.55 | 10.57 | 13.02 | |
| – | – | – | -2.06 | -1.74 | -1.95 | -1.96 | -2.01 | -1.96 | -2.04 | 2.04 | 1.89 | 1.57 | 1.52 | -1.40 | -1.52 | -1.65 | -1.87 | -2.06 | -1.88 | -2.04 | -1.97 | -1.94 | -1.80 | -1.80 | -1.72 | -1.78 | -2.88 | -3.03 | -3.36 | -1.18 | -0.83 | -0.99 | -2.06 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.